16698-08-1 → 5,7-Dimethyl-hexahydro-1-[(4-methyl-5-isoquinolinyl)sulfonyl]-1H-1,4-diazepine hydrochloride
Reaction equation
[CH3:1][CH:2]1[CH2:8][CH:7]([CH3:9])[NH:6][CH2:5][CH2:4][NH:3]1.[Cl:10][S:11]([C:14]1[CH:23]=[CH:22][CH:21]=[C:20]2[C:15]=1[C:16]([CH3:24])=[CH:17][N:18]=[CH:19]2)(=[O:13])=[O:12]>>[ClH:10].[CH3:1][CH:2]1[CH2:8][CH:7]([CH3:9])[N:6]([S:11]([C:14]2[CH:23]=[CH:22][CH:21]=[C:20]3[C:15]=2[C:16]([CH3:24])=[CH:17][N:18]=[CH:19]3)(=[O:12])=[O:13])[CH2:5][CH2:4][NH:3]1Participants
3
Procedure
Using 0.77 g of 5,7-dimethyl-hexahydro-1H-1,4-diazepine and 0.48 g of 5-chlorosulfonyl-4-methylisoquinoline, the procedure of Example 1 was otherwise repeated to provide 0.50 g of the objective compound (white crystals).
Sources & evidence
- ORD record
- ord-d44a91c506c74c64a85e60ac8d869e28
- Source dataset
- uspto-grants-2000_11